For E-cad, there was a significant difference in expression level between hereditary breast cancer patients and the non-hereditary breast cancer patients (X2 = 11.15, P < 0.005), as well as between CHBC and non-hereditary breast cancer patients (X2 = 9.75, P < 0.005). Here, CDH1 is linked to breast cancer.